AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Insulin Human in South Africa
8 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| INSUMAN RAPID (300 IU/3 ML) | 36/21.1/0074 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 19 Apr 2023 |
| INSUMAN BASAL (300 IU/3 ML) | 36/21.1/0077 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 26 Jan 2023 |
| INSUMAN COMB 30/70 (1000 IU/10 ML) | 36/21.1/0082 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 17 Feb 2022 |
| INSUMAN RAPID (1000 IU/10 ML) | 36/21.1/0076 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 17 Feb 2022 |
| INSUMAN BASAL (1000 IU/10 ml) | 36/21.1/0079 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 17 Feb 2022 |
| DIABULYN N | 43/21.1/0213 | Ascendis Pharma (Pty) Ltd | active | 1 Jan 1900 |
| INSUMAN COMB 30/70 (300 IU/3 ml) | 36/21.1/0080 | Sanofi-Aventis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| DIABULYN R | 43/21.1/0214 | Ascendis Pharma (Pty) Ltd | active | 1 Jan 1900 |
Insulin Human — SAHPRA Registration Details
SAHPRA (South Africa) has 8 registered products containing Insulin Human, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Insulin Human registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.